Widespread uptake of continuous glucocse monitors (CGM) can facilitate telemedicine to remote places and remove healthcare disparities.

Healthcare professionals, type 1 diabetes patients, AND payers will win, says Trustee David Panzirer in Diabetes Technology & Therapeutics here.